{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T18:04:36Z","timestamp":1785175476960,"version":"3.55.0"},"reference-count":83,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Rewind Therapeutics NV"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Myelination, driven by differentiation of oligodendrocyte precursor cells, is critical for metabolic and structural support and efficient axonal signal transmission in neurons. Loss of myelin is a hallmark of multiple sclerosis and other devastating demyelinating disorders. As demyelination persists, neurons become increasingly vulnerable, leading to neurodegeneration and chronic disability. Restoring myelin through endogenous repair mechanisms offers a promising therapeutic approach to mitigate progressive neuronal loss. One key regulator of myelination is the G protein-coupled receptor 17, GPR17, whose chronic upregulation in oligodendrocyte precursor cells is commonly seen with myelin injury. In line with single-nucleus transcriptomic data showing predominant expression of GPR17 in committed oligodendrocyte precursor cells, our postmortem immunohistochemical analyses of MS patient tissue revealed a significant upregulation of GPR17\n                    <jats:sup>+<\/jats:sup>\n                    \/BCAS1\n                    <jats:sup>+<\/jats:sup>\n                    oligodendrocyte precursor cells adjacent to and in demyelinated lesions. Importantly, remyelinated lesions lacked GPR17 immunoreactivity, consistent with a model in which sustained GPR17 expression is associated with demyelination and impaired oligodendrocyte precursor cell differentiation. To test the impact of pharmacological GPR17 inhibition on remyelination, we evaluated the effects of a novel, selective GPR17 antagonist in cuprizone-induced murine demyelination models. This toxin-induced approach has been widely used to study mechanisms of de- and remyelination, in the absence of the full inflammatory complexity of demyelinating diseases such as multiple sclerosis. We show that oral treatment results in robust functional recovery consistent with remyelination, as evidenced by improved spatial memory and recovery of visual evoked potential latency delays. GPR17 antagonism also accelerated structural remyelination in the corpus callosum and optic nerve. Together, these findings support a role for pharmacological GPR17 antagonism in promoting remyelination and highlight this G protein-coupled receptor as a promising therapeutic target for demyelinating disorders.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0354525","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:36:33Z","timestamp":1785173793000},"page":"e0354525","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Selective GPR17 antagonism enhances structural and functional recovery in animal models of demyelination"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5916-987X","authenticated-orcid":true,"given":"Dille","family":"De Herdt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evy","family":"Lefevere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Hartvig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiel","family":"Geeraerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chih","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2296-2396","authenticated-orcid":true,"given":"J. Q. Alida","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Duvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Burbidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Harmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0396-9952","authenticated-orcid":true,"given":"Irene","family":"Knuesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"1","key":"pone.0354525.ref001","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020479","article-title":"Oligodendrocytes: Myelination and axonal support","volume":"8","author":"M Simons","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"21","key":"pone.0354525.ref002","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.neuron.2022.09.023","article-title":"CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities","volume":"110","author":"RJM Franklin","year":"2022","journal-title":"Neuron"},{"issue":"11","key":"pone.0354525.ref003","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s40265-025-02212-x","article-title":"The road to remyelination in multiple sclerosis: Breakthroughs, challenges, and considerations for future trial design","volume":"85","author":"L Zuroff","year":"2025","journal-title":"Drugs"},{"key":"pone.0354525.ref004","doi-asserted-by":"crossref","first-page":"1135540","DOI":"10.3389\/fimmu.2023.1135540","article-title":"Central nervous system demyelinating diseases: Glial cells at the hub of pathology","volume":"14","author":"VG Coutinho Costa","year":"2023","journal-title":"Front Immunol"},{"issue":"7761","key":"pone.0354525.ref005","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","article-title":"Single-cell transcriptomic analysis of Alzheimer\u2019s disease","volume":"570","author":"H Mathys","year":"2019","journal-title":"Nature"},{"issue":"7","key":"pone.0354525.ref006","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.3390\/ijms22073426","article-title":"Defective oligodendroglial lineage and demyelination in amyotrophic lateral sclerosis","volume":"22","author":"E Traiffort","year":"2021","journal-title":"Int J Mol Sci"},{"key":"pone.0354525.ref007","doi-asserted-by":"crossref","first-page":"17562864241233041","DOI":"10.1177\/17562864241233041","article-title":"A review of Bruton\u2019s tyrosine kinase inhibitors in multiple sclerosis","volume":"17","author":"L Airas","year":"2024","journal-title":"Ther Adv Neurol Disord"},{"key":"pone.0354525.ref008","doi-asserted-by":"crossref","first-page":"106974","DOI":"10.1016\/j.msard.2026.106974","article-title":"Efficacy and safety of Bruton\u2019s tyrosine kinase inhibitors compared to Teriflunomide in relapsing multiple sclerosis: A systematic review and meta-analysis","volume":"107","author":"MVS Sobral","year":"2026","journal-title":"Mult Scler Relat Disord"},{"issue":"15","key":"pone.0354525.ref009","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3390\/cells11152369","article-title":"Rewiring of glucose and lipid metabolism induced by G protein-coupled receptor 17 silencing enables the transition of oligodendrocyte progenitors to myelinating cells","volume":"11","author":"D Marangon","year":"2022","journal-title":"Cells"},{"key":"pone.0354525.ref010","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/brain\/awp147","article-title":"The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury","volume":"132","author":"S Ceruti","year":"2009","journal-title":"Brain"},{"issue":"10","key":"pone.0354525.ref011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003579","article-title":"The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair","volume":"3","author":"D Lecca","year":"2008","journal-title":"PLoS One"},{"issue":"11","key":"pone.0354525.ref012","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nn.2410","article-title":"The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination","volume":"12","author":"Y Chen","year":"2009","journal-title":"Nat Neurosci"},{"issue":"5","key":"pone.0354525.ref013","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/glia.23305","article-title":"Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination","volume":"66","author":"GT Coppolino","year":"2018","journal-title":"Glia"},{"issue":"1","key":"pone.0354525.ref014","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1038\/s41598-018-22452-0","article-title":"G-protein-coupled receptor Gpr17 regulates oligodendrocyte differentiation in response to lysolecithin-induced demyelination","volume":"8","author":"C Lu","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"pone.0354525.ref015","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s12035-018-1146-1","article-title":"G-protein-coupled receptor Gpr17 expression in two multiple sclerosis remyelination models","volume":"56","author":"S Nyamoya","year":"2019","journal-title":"Mol Neurobiol"},{"key":"pone.0354525.ref016","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.lfs.2019.03.045","article-title":"The role of orphan G protein-coupled receptors in the pathophysiology of multiple sclerosis: A review","volume":"224","author":"MS Alavi","year":"2019","journal-title":"Life Sci"},{"issue":"12","key":"pone.0354525.ref017","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/glia.21237","article-title":"The GPR17 receptor in NG2 expressing cells: Focus on in vivo cell maturation and participation in acute trauma and chronic damage","volume":"59","author":"E Boda","year":"2011","journal-title":"Glia"},{"issue":"19","key":"pone.0354525.ref018","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1038\/sj.emboj.7601341","article-title":"The orphan receptor GPR17 identified as a new dual uracil nucleotides\/cysteinyl-leukotrienes receptor","volume":"25","author":"P Ciana","year":"2006","journal-title":"EMBO J"},{"issue":"3","key":"pone.0354525.ref019","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11302-013-9366-3","article-title":"Changes of the GPR17 receptor, a new target for neurorepair, in neurons and glial cells in patients with traumatic brain injury","volume":"9","author":"H Franke","year":"2013","journal-title":"Purinergic Signal"},{"issue":"2","key":"pone.0354525.ref020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/path.6381","article-title":"Characterisation of GPR17-expressing oligodendrocyte precursors in human ischaemic lesions and correlation with reactive glial responses","volume":"265","author":"S Raffaele","year":"2025","journal-title":"J Pathol"},{"issue":"9","key":"pone.0354525.ref021","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.3390\/ijms22094574","article-title":"The distribution of GPR17-expressing cells correlates with white matter inflammation status in brain tissues of multiple sclerosis patients","volume":"22","author":"J Angelini","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"pone.0354525.ref022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231483","article-title":"Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosis","volume":"15","author":"C Parravicini","year":"2020","journal-title":"PLoS One"},{"issue":"6","key":"pone.0354525.ref023","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.cellsig.2014.02.016","article-title":"Does GRK-\u03b2 arrestin machinery work as a \u201cswitch on\u201d for GPR17-mediated activation of intracellular signaling pathways?","volume":"26","author":"S Daniele","year":"2014","journal-title":"Cell Signal"},{"key":"pone.0354525.ref024","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.phrs.2019.02.025","article-title":"Improvement of fiber connectivity and functional recovery after stroke by montelukast, an available and safe anti-asthmatic drug","volume":"142","author":"P Gelosa","year":"2019","journal-title":"Pharmacol Res"},{"issue":"298","key":"pone.0354525.ref025","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004350","article-title":"Decoding signaling and function of the orphan G protein-coupled receptor GPR17 with a small-molecule agonist","volume":"6","author":"S Hennen","year":"2013","journal-title":"Sci Signal"},{"issue":"10","key":"pone.0354525.ref026","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/glia.23807","article-title":"Regulation and signaling of the GPR17 receptor in oligodendroglial cells","volume":"68","author":"D Lecca","year":"2020","journal-title":"Glia"},{"issue":"41","key":"pone.0354525.ref027","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1523\/JNEUROSCI.0898-16.2016","article-title":"Olig2-Targeted G-protein-coupled receptor Gpr17 regulates oligodendrocyte survival in response to lysolecithin-induced demyelination","volume":"36","author":"Z Ou","year":"2016","journal-title":"J Neurosci"},{"issue":"3","key":"pone.0354525.ref028","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/glia.21107","article-title":"Expression of the new P2Y-like receptor GPR17 during oligodendrocyte precursor cell maturation regulates sensitivity to ATP-induced death","volume":"59","author":"S Ceruti","year":"2011","journal-title":"Glia"},{"issue":"7","key":"pone.0354525.ref029","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/glia.22506","article-title":"UDP-glucose enhances outward K(+) currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors","volume":"61","author":"E Coppi","year":"2013","journal-title":"Glia"},{"issue":"4","key":"pone.0354525.ref030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bph.15969","article-title":"Identification and characterization of select oxysterols as ligands for GPR17","volume":"180","author":"AW Harrington","year":"2023","journal-title":"Br J Pharmacol"},{"key":"pone.0354525.ref031","article-title":"C1q(+) macrophage-tumor cell interaction promoted tumorigenesis via GPR17\/PI3K\/AKT pathway induced DNA hypermethylation in nasopharyngeal carcinoma","author":"Y Liu","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"21","key":"pone.0354525.ref032","doi-asserted-by":"crossref","first-page":"19365","DOI":"10.1021\/acs.jmedchem.4c01755","article-title":"Discovery of anthranilic acid derivatives as antagonists of the pro-inflammatory orphan G protein-coupled receptor GPR17","volume":"67","author":"NM Boshta","year":"2024","journal-title":"J Med Chem"},{"issue":"7","key":"pone.0354525.ref033","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.tips.2025.05.001","article-title":"GPR17 - orphan G protein-coupled receptor with therapeutic potential","volume":"46","author":"M Lewash","year":"2025","journal-title":"Trends Pharmacol Sci"},{"issue":"12","key":"pone.0354525.ref034","doi-asserted-by":"crossref","first-page":"10593","DOI":"10.1074\/jbc.M110.162867","article-title":"Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation","volume":"286","author":"M Fumagalli","year":"2011","journal-title":"J Biol Chem"},{"issue":"2","key":"pone.0354525.ref035","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1074\/jbc.M115.683953","article-title":"The orphan G protein-coupled receptor GPR17 negatively regulates oligodendrocyte differentiation via G\u03b1i\/o and its downstream effector molecules","volume":"291","author":"K Simon","year":"2016","journal-title":"J Biol Chem"},{"key":"pone.0354525.ref036","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.1038\/ncomms9466","article-title":"Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug","volume":"6","author":"J Marschallinger","year":"2015","journal-title":"Nat Commun"},{"issue":"20","key":"pone.0354525.ref037","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2217635120","article-title":"MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial","volume":"120","author":"E Caverzasi","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10111","key":"pone.0354525.ref038","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","article-title":"Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): A randomised, controlled, double-blind, crossover trial","volume":"390","author":"AJ Green","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"pone.0354525.ref039","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00415-016-8341-7","article-title":"Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: A randomised, single-blind, phase II study","volume":"264","author":"CJ Schwartzbach","year":"2017","journal-title":"J Neurol"},{"issue":"9","key":"pone.0354525.ref040","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S1474-4422(21)00179-4","article-title":"Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): A randomised, double-blind, placebo-controlled, parallel-group, phase 2a study","volume":"20","author":"JWL Brown","year":"2021","journal-title":"Lancet Neurol"},{"issue":"9","key":"pone.0354525.ref041","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S1474-4422(19)30137-1","article-title":"Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): A randomised, placebo-controlled, phase 2 trial","volume":"18","author":"D Cadavid","year":"2019","journal-title":"Lancet Neurol"},{"issue":"8","key":"pone.0354525.ref042","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/WNL.0000000000012323","article-title":"Secondary progressive multiple sclerosis: New insights","volume":"97","author":"BAC Cree","year":"2021","journal-title":"Neurology"},{"issue":"12","key":"pone.0354525.ref043","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/s41593-019-0539-4","article-title":"A single-cell atlas of entorhinal cortex from individuals with Alzheimer\u2019s disease reveals cell-type-specific gene expression regulation","volume":"22","author":"A Grubman","year":"2019","journal-title":"Nat Neurosci"},{"issue":"7745","key":"pone.0354525.ref044","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41586-019-0903-2","article-title":"Altered human oligodendrocyte heterogeneity in multiple sclerosis","volume":"566","author":"S J\u00e4kel","year":"2019","journal-title":"Nature"},{"issue":"7772","key":"pone.0354525.ref045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41586-019-1404-z","article-title":"Neuronal vulnerability and multilineage diversity in multiple sclerosis","volume":"573","author":"L Schirmer","year":"2019","journal-title":"Nature"},{"issue":"6441","key":"pone.0354525.ref046","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1126\/science.aav8130","article-title":"Single-cell genomics identifies cell type-specific molecular changes in autism","volume":"364","author":"D Velmeshev","year":"2019","journal-title":"Science"},{"issue":"5","key":"pone.0354525.ref047","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"A Butler","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"5","key":"pone.0354525.ref048","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nbt.3192","article-title":"Spatial reconstruction of single-cell gene expression data","volume":"33","author":"R Satija","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"7","key":"pone.0354525.ref049","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"T Stuart","year":"2019","journal-title":"Cell"},{"key":"pone.0354525.ref050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jneuroim.2017.04.007","article-title":"Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology","volume":"309","author":"DAE Hendrickx","year":"2017","journal-title":"J Neuroimmunol"},{"issue":"4","key":"pone.0354525.ref051","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00401-018-1818-y","article-title":"Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: A retrospective autopsy cohort analysis","volume":"135","author":"S Luchetti","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"1","key":"pone.0354525.ref052","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-016-1653-y","article-title":"An updated histological classification system for multiple sclerosis lesions","volume":"133","author":"T Kuhlmann","year":"2017","journal-title":"Acta Neuropathol"},{"key":"pone.0354525.ref053","unstructured":"Pericolle VHD, Vanherck JCAL, Marchand ADM, Duvey GAJ, Pinto RMGC. 3-pyrrolylsulfonamide compounds as GPR17 antagonists. 2022."},{"key":"pone.0354525.ref054","unstructured":"Pinto RMGC, Duvey GAJ, Vanherck J-CAL, Marchand ADM, Pericolle VHD. Fused pyrrolyl-sulfonamide compounds for the treatment of GPR17-mediated disorders. 2024."},{"issue":"1","key":"pone.0354525.ref055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","article-title":"The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system","volume":"11","author":"GK Matsushima","year":"2001","journal-title":"Brain Pathol"},{"key":"pone.0354525.ref056","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neubiorev.2014.10.004","article-title":"Cellular and molecular neuropathology of the cuprizone mouse model: Clinical relevance for multiple sclerosis","volume":"47","author":"J Praet","year":"2014","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"pone.0354525.ref057","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301557RR","article-title":"The sphingosine-1-phosphate receptor 1 modulator ponesimod repairs cuprizone-induced demyelination and induces oligodendrocyte differentiation","volume":"38","author":"E Willems","year":"2024","journal-title":"FASEB J"},{"key":"pone.0354525.ref058","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bbr.2013.12.009","article-title":"An automated maze task for assessing hippocampus-sensitive memory in mice","volume":"261","author":"EY Pioli","year":"2014","journal-title":"Behav Brain Res"},{"issue":"1","key":"pone.0354525.ref059","doi-asserted-by":"crossref","first-page":"14722","DOI":"10.1038\/s41598-023-41996-4","article-title":"A quantitative analysis of spontaneous alternation behaviors on a Y-maze reveals adverse effects of acute social isolation on spatial working memory","volume":"13","author":"J Kim","year":"2023","journal-title":"Sci Rep"},{"issue":"3","key":"pone.0354525.ref060","article-title":"Assessing spatial working memory using the spontaneous alternation y-maze test in aged male mice","volume":"9","author":"EAK Prieur","year":"2019","journal-title":"Bio Protoc"},{"key":"pone.0354525.ref061","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-7862-5_1","article-title":"Electron microscopy for the analysis of peripheral nerve myelin","volume":"1791","author":"C Ferri","year":"2018","journal-title":"Methods Mol Biol"},{"issue":"3","key":"pone.0354525.ref062","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1523\/JNEUROSCI.22-03-00698.2002","article-title":"Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau","volume":"22","author":"C Klein","year":"2002","journal-title":"J Neurosci"},{"issue":"1","key":"pone.0354525.ref063","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2990.2000.00217.x","article-title":"Staging of multiple sclerosis (MS) lesions: Pathology of the time frame of MS","volume":"26","author":"P van der Valk","year":"2000","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"pone.0354525.ref064","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/WNO.0000000000000704","article-title":"Visual evoked potentials as a biomarker in multiple sclerosis and associated optic neuritis","volume":"38","author":"L Leocani","year":"2018","journal-title":"J Neuroophthalmol"},{"key":"pone.0354525.ref065","doi-asserted-by":"crossref","first-page":"820155","DOI":"10.3389\/fnins.2022.820155","article-title":"Visual evoked potentials to monitor myelin cuprizone-induced functional changes","volume":"16","author":"S Marenna","year":"2022","journal-title":"Front Neurosci"},{"issue":"10","key":"pone.0354525.ref066","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S1474-4422(20)30306-9","article-title":"Cognition in multiple sclerosis: Charcot was right","volume":"19","author":"RHB Benedict","year":"2020","journal-title":"Lancet Neurol"},{"issue":"5","key":"pone.0354525.ref067","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/ijms21051852","article-title":"The GPR17 Receptor-A promising goal for therapy and a potential marker of the neurodegenerative process in multiple sclerosis","volume":"21","author":"A Dziedzic","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0354525.ref068","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12974-023-02958-9","article-title":"Knockdown and inhibition of hippocampal GPR17 attenuates lipopolysaccharide-induced cognitive impairment in mice","volume":"20","author":"Y Liang","year":"2023","journal-title":"J Neuroinflammation"},{"issue":"6291","key":"pone.0354525.ref069","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1126\/science.aaf6463","article-title":"Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system","volume":"352","author":"S Marques","year":"2016","journal-title":"Science"},{"issue":"11","key":"pone.0354525.ref070","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/glia.24426","article-title":"The committed oligodendrocyte precursor cell, a newly-defined intermediate progenitor cell type in oligodendroglial lineage","volume":"71","author":"M Fang","year":"2023","journal-title":"Glia"},{"issue":"9","key":"pone.0354525.ref071","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020461","article-title":"Transcriptional and epigenetic regulation of oligodendrocyte development and myelination in the central nervous system","volume":"7","author":"B Emery","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"pone.0354525.ref072","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cell.2009.04.031","article-title":"Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination","volume":"138","author":"B Emery","year":"2009","journal-title":"Cell"},{"issue":"2","key":"pone.0354525.ref073","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1101\/gad.215802","article-title":"Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10","volume":"16","author":"CC Stolt","year":"2002","journal-title":"Genes Dev"},{"issue":"11","key":"pone.0354525.ref074","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1093\/brain\/awac207","article-title":"Validating visual evoked potentials as a preclinical, quantitative biomarker for remyelination efficacy","volume":"145","author":"C Cordano","year":"2022","journal-title":"Brain"},{"issue":"1","key":"pone.0354525.ref075","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41467-025-56092-6","article-title":"Incomplete remyelination via therapeutically enhanced oligodendrogenesis is sufficient to recover visual cortical function","volume":"16","author":"G Della-Flora Nunes","year":"2025","journal-title":"Nat Commun"},{"key":"pone.0354525.ref076","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cnp.2019.03.002","article-title":"The electrophysiological assessment of visual function in Multiple Sclerosis","volume":"4","author":"JL Barton","year":"2019","journal-title":"Clin Neurophysiol Pract"},{"issue":"10","key":"pone.0354525.ref077","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.3390\/jcm11102936","article-title":"Working memory phenotypes in early multiple sclerosis: Appraisal of phenotype frequency, progression and test sensitivity","volume":"11","author":"M Clough","year":"2022","journal-title":"J Clin Med"},{"issue":"2","key":"pone.0354525.ref078","doi-asserted-by":"crossref","first-page":"101304","DOI":"10.1016\/j.xpro.2022.101304","article-title":"Transmission electron microscopic analysis of myelination in the murine central nervous system","volume":"3","author":"Y Wang","year":"2022","journal-title":"STAR Protoc"},{"key":"pone.0354525.ref079","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcdb.2020.09.009","article-title":"Revisiting remyelination: Towards a consensus on the regeneration of CNS myelin","volume":"116","author":"RJM Franklin","year":"2021","journal-title":"Semin Cell Dev Biol"},{"issue":"11","key":"pone.0354525.ref080","article-title":"A GPR17-cAMP-lactate signaling axis in oligodendrocytes regulates whole-body metabolism","volume":"26","author":"Z Ou","year":"2019","journal-title":"Cell Rep"},{"key":"pone.0354525.ref081","doi-asserted-by":"crossref","first-page":"102194","DOI":"10.1016\/j.coph.2022.102194","article-title":"Breaking the barriers to remyelination in multiple sclerosis","volume":"63","author":"M Gharagozloo","year":"2022","journal-title":"Curr Opin Pharmacol"},{"issue":"6","key":"pone.0354525.ref082","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001066","article-title":"Remyelination trials: Are we expecting the unexpected?","volume":"8","author":"A Klistorner","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"pone.0354525.ref083","doi-asserted-by":"crossref","first-page":"103539","DOI":"10.1016\/j.msard.2022.103539","article-title":"Remyelination trial failures: Repercussions of ignoring neurorehabilitation and exercise in repair","volume":"58","author":"M Ploughman","year":"2022","journal-title":"Mult Scler Relat Disord"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0354525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:36:50Z","timestamp":1785173810000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0354525"}},"subtitle":[],"editor":[{"given":"Nagendra Kumar","family":"Rai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":83,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0354525","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]}}}